Skip to main content

Helicos Shares Rise on Instrument Sale

NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences climbed around 16 percent in early trade on the Nasdaq after the firm announced that it had sold one of its Helicos Genetic Analysis Systems to the Turku Centre for Biotechnology in Turku, Finland.

The firm's shares were up $.18 at $1.30 less than an hour after the market opened.

The Turku Centre for Biotechnology's purchase represents the 10th sale of Helicos' HeliScope Single Molecule Sequencer. According to Helicos, there are 12 Helicos systems currently installed and operating at customer sites around the world.

Ron Lowy, Helicos' CEO, said in a statement that the firm averaged one placement per month during 2009 for the Helicos system.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.